G&S Capital »

Vertex Pharmaceuticals Incorporated shares owned by G&S Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by G&S Capital from 13F filings

Historical chart of G&S Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by G&S Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by G&S Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $288k 689 418.01
2023-12-31 $284k 697 406.89
2023-09-30 $294k 846 347.74
2023-06-30 $298k 846 351.91
2023-03-31 $422k 1.3k 315.07
2022-12-31 $406k 1.4k 288.78
2020-06-30 $309k 1.1k 290.69

More positions owned by G&S Capital

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Value Etf (VTV)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Chevron Corporation (CVX)
Ishares Msci Eurzone Etf (EZU)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
First Tr Exch Traded Fd Iii Instl Pfd Secs (FPEI)
Williams Companies (WMB)
Ishares Tr Core S&p Scp Etf (IJR)
Apple (AAPL)

View all positions for G&S Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated